The Medical Affairs Professional Society (MAPS) is honored to announce the inclusion of Johnson and Johnson Pharmaceuticals (JNJ) in the MAPS Industry Partnership Program
Through this course you will recognize terms such as artificial intelligence (AI), machine learning (ML), deep learning, and neural networks to arrive at best decisions and insights needed for success.
This paper provides a brief overview of the results of two MAPS insight surveys as well as suggested next steps to develop a common framework that biopharma companies can use to achieve a more consistent and effective approach to generating medical insights as a principal driver for strategy shaping and choice of tactics.